{"id":"https://openalex.org/W4361943137","doi":"https://doi.org/10.1158/1078-0432.c.6517432","title":"Data from Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters","display_name":"Data from Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361943137","doi":"https://doi.org/10.1158/1078-0432.c.6517432"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6517432","doi":"https://doi.org/10.1158/1078-0432.c.6517432","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6517432","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6517432","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077955893","display_name":"Shuiying Hu","orcid":"https://orcid.org/0000-0002-9806-7734","observed_orcids":["https://orcid.org/0000-0002-9806-7734"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuiying Hu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089372630","display_name":"Zhaoyuan Chen","orcid":"https://orcid.org/0009-0004-3453-6820","observed_orcids":["https://orcid.org/0009-0004-3453-6820"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhaoyuan Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048593345","display_name":"Ryan M. Franke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan Franke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034265050","display_name":"Shelley J. Orwick","orcid":"https://orcid.org/0000-0002-4537-1409","observed_orcids":["https://orcid.org/0000-0002-4537-1409"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shelley Orwick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100748391","display_name":"Ming Zhao","orcid":"https://orcid.org/0000-0002-4728-9206","observed_orcids":["https://orcid.org/0000-0002-4728-9206"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ming Zhao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015341987","display_name":"Michelle A. Rudek","orcid":"https://orcid.org/0000-0001-5739-6868","observed_orcids":["https://orcid.org/0000-0001-5739-6868"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle A. Rudek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065279964","display_name":"Alex Sparreboom","orcid":"https://orcid.org/0000-0003-2660-6644","observed_orcids":["https://orcid.org/0000-0003-2660-6644"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Sparreboom","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharyn D. Baker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":1.0},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.9179999828338623},{"id":"https://openalex.org/keywords/solute-carriers","display_name":"solute carrier transporters","score":0.8040000200271606},{"id":"https://openalex.org/keywords/abc-transporters","display_name":"ABC transporters","score":0.878000020980835},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9079999923706055},{"id":"https://openalex.org/keywords/abcg2","display_name":"ABCG2","score":0.6729999780654907},{"id":"https://openalex.org/keywords/mrp2","display_name":"MRP2","score":0.8230000138282776},{"id":"https://openalex.org/keywords/abcc4","display_name":"ABCC4","score":0.9980000257492065},{"id":"https://openalex.org/keywords/oatp1a2","display_name":"OATP1A2","score":0.7919999957084656},{"id":"https://openalex.org/keywords/oatp1b1","display_name":"OATP1B1","score":0.9919999837875366},{"id":"https://openalex.org/keywords/oatp1b3","display_name":"OATP1B3","score":0.9779999852180481},{"id":"https://openalex.org/keywords/oct1","display_name":"OCT1","score":0.8629999756813049},{"id":"https://openalex.org/keywords/octn1","display_name":"OCTN1","score":0.7889999747276306},{"id":"https://openalex.org/keywords/octn2","display_name":"OCTN2","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-uptake","display_name":"drug uptake","score":0.6769999861717224},{"id":"https://openalex.org/keywords/drug-efflux-inhibition","display_name":"drug efflux inhibition","score":0.7739999890327454},{"id":"https://openalex.org/keywords/plasma-pharmacokinetics","display_name":"plasma pharmacokinetics","score":0.9020000100135803},{"id":"https://openalex.org/keywords/brain-penetration","display_name":"brain penetration","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C36201501","wikidata":"https://www.wikidata.org/wiki/Q17907816","display_name":"Multidrug resistance-associated protein 2","level":5,"score":0.6912040710449219},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.6823811531066895},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.657596230506897},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6253076195716858},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.6233401298522949},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.6180508136749268},{"id":"https://openalex.org/C44312359","wikidata":"https://www.wikidata.org/wiki/Q286958","display_name":"ATP-binding cassette transporter","level":4,"score":0.607170820236206},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.594150960445404},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5551483631134033},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.5518801212310791},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.45476749539375305},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.4506625235080719},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4326026439666748},{"id":"https://openalex.org/C123584848","wikidata":"https://www.wikidata.org/wiki/Q18034026","display_name":"Organic anion transporter 1","level":4,"score":0.43204888701438904},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.4277638792991638},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35289621353149414},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28976958990097046},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28152790665626526},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.13166841864585876},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.11181482672691345},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.08990082144737244},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.078470379114151},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6517432","doi":"https://doi.org/10.1158/1078-0432.c.6517432","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6517432","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6517432","doi":"https://doi.org/10.1158/1078-0432.c.6517432","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6517432","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2168381076","https://openalex.org/W2161000665","https://openalex.org/W1982307539","https://openalex.org/W2318852361","https://openalex.org/W2328784583","https://openalex.org/W2120568874","https://openalex.org/W2138741043","https://openalex.org/W2142636931","https://openalex.org/W2033581016","https://openalex.org/W4220832362"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"To":[2],"compare":[3],"side-by-side":[4],"the":[5,19,24,36,41,119,128,152,212],"uptake":[6,15,111],"of":[7,18,29,38,47,53,118,165],"sorafenib":[8,184,199],"and":[9,21,27,35,44,82,123,133,138,181,185,200,240],"sunitinib":[10,134,201],"in":[11,40,59,87,103,188,237],"vitro":[12],"by":[13,26,116,151,179],"human":[14,71,91],"solute":[16,121],"carriers":[17,122],"SLC22A":[20],"SLCO":[22],"families,":[23],"transport":[25,209],"inhibition":[28,83],"efflux":[30,221],"ATP-binding":[31],"cassette":[32],"(ABC)":[33],"transporters,":[34],"role":[37],"ABCB1":[39,146],"plasma":[42,171],"pharmacokinetics":[43],"brain":[45,174],"penetration":[46,175],"these":[48,225,227],"agents.":[49],"Experimental":[50],"Design:":[51],"Uptake":[52],"[3H]sorafenib":[54],"or":[55,63,79,95],"[3H]sunitinib":[56],"was":[57,112,124,176],"assessed":[58],"Xenopus":[60],"laevis":[61],"oocytes":[62],"mammalian":[64],"cells":[65,88],"transfected":[66,89],"with":[67,90],"cDNAs":[68],"coding":[69],"for":[70,145,183,219],"OATP1A2,":[72],"OATP1B1,":[73],"OATP1B3,":[74],"OCT1,":[75],"OAT2,":[76],"OAT3,":[77],"OCTN1,":[78],"OCTN2.":[80],"Efflux":[81],"experiments":[84],"were":[85,101,148],"conducted":[86],"ABCB1,":[92],"ABCG2,":[93],"ABCC2,":[94],"ABCC4.":[96],"In":[97],"vivo":[98],"pharmacokinetic":[99],"studies":[100],"done":[102],"knockout":[104,189],"mice":[105],"lacking":[106],"Abcb1-type":[107],"transporters.":[108,155,162,222],"Results:":[109],"Intracellular":[110],"not":[113,149,203],"appreciably":[114],"affected":[115,150],"any":[117],"studied":[120],"minute":[125],"relative":[126],"to":[127,142,205,210,234],"respective":[129],"prototypical":[130],"substrates.":[131],"Sorafenib":[132],"showed":[135],"concentration-dependent":[136],"(1":[137],"10":[139],"\u03bcmol/L),":[140],"low":[141],"moderate":[143],"affinity":[144],"but":[147,173],"other":[153,195],"ABC":[154,161,220],"Both":[156],"agents":[157],"inhibited":[158],"all":[159],"tested":[160],"The":[163],"absence":[164],"Abcb1":[166],"had":[167],"no":[168],"affect":[169],"on":[170,207,224],"pharmacokinetics,":[172],"moderately":[177],"increased":[178],"1.9-":[180],"2.9-fold":[182],"sunitinib,":[186],"respectively,":[187],"animals":[190],"versus":[191],"controls.":[192],"Conclusions:":[193],"Unlike":[194],"tyrosine":[196],"kinase":[197],"inhibitors,":[198],"do":[202],"appear":[204],"rely":[206],"active":[208],"enter":[211],"cell":[213],"nor":[214],"are":[215],"they":[216],"high-affinity":[217],"substrates":[218],"Based":[223],"characteristics,":[226],"two":[228],"drugs":[229],"may":[230],"be":[231],"less":[232],"susceptible":[233],"transporter-mediated":[235],"alterations":[236],"systemic":[238],"exposure":[239],"transporter-related":[241],"resistance":[242],"mechanisms.":[243],"(Clin":[244],"Cancer":[245],"Res":[246],"2009;15(19):6062\u20139)":[247]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}